Brazilians on board with Oxitec's genetically engineered mosquitoes

|By:, SA News Editor

Intrexon's (NYSE:XON) Oxitec unit reports that it has overwhelming support for its engineered mosquito program in Brazil as a method to control the incidence of diseases like Zika, dengue and chikungunya spread by the Aedes aegypti mosquito.

In an independent survey conducted in early November, almost 93% of the residents in Piracicaba city support the Friendly Aedes project which began in April 2015 and now encompasses an area of 60K people.

A trial in the Florida Keys is set to go if local opposition can be overcome in Key Haven, the site of the study. The local Mosquito Control Board backs the project.